| Name | 2-(4,6-Dichloropyrimidin-2-yl)acetonitrile |
|---|---|
| Synonyms |
2-(4,6-dichloropyrimidin-2-yl)acetonitrile
(4,6-Dichloro-2-pyrimidinyl)acetonitrile |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 305.9±32.0 °C at 760 mmHg |
| Molecular Formula | C6H3Cl2N3 |
| Molecular Weight | 188.014 |
| Flash Point | 138.8±25.1 °C |
| Exact Mass | 186.970398 |
| PSA | 49.57000 |
| LogP | 1.04 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.576 |
| Storage condition | 2-8°C |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933599090 |
|
~74%
63155-43-1 |
| Literature: Amgen Inc. Patent: US2007/299080 A1, 2007 ; Location in patent: Page/Page column 80-81 ; |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933599090 |
|---|---|
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |